Sentence examples for differences in routes of from inspiring English sources

This may be explained by differences in routes of exposure or rates of metabolism and excretion (Frederiksen et al. 2007).

Some of the controversies between our results in vitro and in vivo findings can possibly be explained by differences in routes of administration and dosages of steroid hormone used.

Furthermore, prescribing a biological agent is an important decision that can greatly impact the quality of life of a patient and can be associated with varying medical costs, owing to differences in routes of administration (depending on the agent).

Air pollution measurements may not adequately reflect the absorbed dose for the individual because of interindividual differences in routes of exposure and physiological factors such as breathing rate and ventilation volume, metabolism, and excretion.

These discrepancies could be due to the differences in route of inoculation in two studies.

The species differences in route of clearance have been interpreted as indicating that the value for clearance of unconjugated (bioactive) BPA must also be very different between rodents and primates.

Differences in route of transmission likely explain why Campylobacter spp. cases are generally more likely to occur sporadically and why norovirus cases are more likely to be part of an outbreak (6 – 9 ).

First, the unavailability for this study of route to diagnosis, previously shown to affect short-term survival (McPhail et al, 2013), means that some of the excess mortality attributed to older age and higher stage might be a result of differences in route of presentation.

Although differences in route of administration and number of booster doses administered prevent comparison with other studies, seroprotection was reported in 88.2% of adults with diabetes who received the thymopentin adjuvant and in 100.0% of previously nonresponding hemodialysis/chronic kidney disease patients with diabetes who had received TT before vaccination.

The difference in routes of administration and dosing regimens between infliximab, etanercept, and adalimumab raises the question of whether these differences affect adherence to therapy and therapeutic outcomes.

The remainder may be explained by the difference in route of infection.